CASI
CASI Pharmaceuticals, Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.15
+3.08%Latest reported
- Last report date
- Nov 14, 2025
- EPS actual
- -$0.67
- EPS estimate
- -$0.40
- Revenue actual
- $3.1M
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 6
- EPS misses (12Q)
- 6
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- -48.8%
- Revenue beats (12Q)
- 5
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Nov 14, 2025 | -$0.40 | -$0.67 | Miss -67.50% | $3.1M |
| Aug 29, 2025 | -$0.47 | -$0.86 | Miss -82.98% | $4.2M |
| May 16, 2025 | -$0.61 | -$0.69 | Miss -13.11% | $6.2M |
| Mar 31, 2025 | -$0.60 | -$0.79 | Miss -31.67% | $13.4M |
| Nov 15, 2024 | -$0.62 | -$0.55 | Beat 11.29% | $7.8M |
| Aug 16, 2024 | -$0.63 | -$0.52 | Beat 17.46% | $4.0M |
| Nov 14, 2023 | -$0.56 | -$0.35 | Beat 37.50% | $8.8M |
| Aug 11, 2023 | -$0.50 | -$0.77 | Miss -54.00% | $9.8M |
| Nov 14, 2022 | -$0.51 | -$0.38 | Beat 25.49% | $10.2M |
| Aug 12, 2022 | -$0.65 | -$0.56 | Beat 13.85% | $8.6M |
| May 12, 2022 | -$1.00 | -$0.60 | Beat 40.00% | $9.1M |
| Nov 12, 2021 | -$0.60 | -$0.70 | Miss -16.67% | $8.1M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 14, 2025